Argus raises target for Cencora stock to USD 380.00
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Argus has increased its price target for Cencora (COR) stock from USD 340.00 to USD 380.00. This follows Cencora's agreement to acquire American Oncology Network for USD 2.4 billion and an upward revision of its fiscal 2026 adjusted diluted earnings per share guidance. Cencora is set to release its fourth-quarter fiscal 2026 results on November 4, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.